Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 2
1969 6
1971 2
1972 1
1979 1
1986 1
1987 1
1988 1
1989 1
1994 1
1995 1
1997 1
2001 1
2002 1
2003 2
2004 3
2005 5
2006 4
2007 1
2008 1
2009 2
2010 2
2011 1
2012 2
2013 5
2014 4
2016 2
2017 4
2018 1
2019 1
2020 3
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

60 results
Results by year
Filters applied: . Clear all
Page 1
Myelopathic onychodystrophy.
Romito S, Monaco S. Romito S, et al. Arch Neurol. 2001 Aug;58(8):1292-3. doi: 10.1001/archneur.58.8.1292. Arch Neurol. 2001. PMID: 11493172 No abstract available.
A multicenter phase II trial of nab-paclitaxel and capecitabine in HER-2 negative and triple- negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?
Ciccarese M, Orlando L, Fedele P, Schiavone P, Maiello E, Cilenti G, Aieta M, Bozza G, Forcignanò R, Febbraro A, Bordonaro R, Romito S, Rinaldi A, Borsellino N, Riccardi F, Pisconti S, Lorusso V, Colucci G, Surico G, Saracino V, Cinieri S; GOIM (Gruppo Oncologico dell’Italia Meridionale). Ciccarese M, et al. Among authors: romito s. Breast J. 2020 Sep;26(9):1857-1859. doi: 10.1111/tbj.13856. Epub 2020 May 20. Breast J. 2020. PMID: 32436244 Clinical Trial. No abstract available.
TRAP1 protein signature predicts outcome in human metastatic colorectal carcinoma.
Maddalena F, Simeon V, Vita G, Bochicchio A, Possidente L, Sisinni L, Lettini G, Condelli V, Matassa DS, Li Bergolis V, Fersini A, Romito S, Aieta M, Ambrosi A, Esposito F, Landriscina M. Maddalena F, et al. Among authors: romito s. Oncotarget. 2017 Mar 28;8(13):21229-21240. doi: 10.18632/oncotarget.15070. Oncotarget. 2017. PMID: 28177905 Free PMC article.
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial.
Dieci MV, Bisagni G, Brandes AA, Frassoldati A, Cavanna L, Giotta F, Aieta M, Gebbia V, Musolino A, Garrone O, Donadio M, Rimanti A, Beano A, Zamagni C, Soto Parra H, Piacentini F, Danese S, Ferro A, Cagossi K, Sarti S, Gambaro AR, Romito S, Bazan V, Amaducci L, Moretti G, Foschini MP, Balduzzi S, Vicini R, D'Amico R, Griguolo G, Guarneri V, Conte PF. Dieci MV, et al. Among authors: romito s. BMC Med. 2019 Nov 21;17(1):207. doi: 10.1186/s12916-019-1445-z. BMC Med. 2019. PMID: 31747948 Free PMC article. Clinical Trial.
Metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with trastuzumab (HEX) as first line therapy of HER-2 positive advanced breast cancer: A phase II trial of the Gruppo Oncologico Italia Meridionale (GOIM).
Orlando L, Lorusso V, Giotta F, Di Maio M, Schiavone P, Fedele P, Quaranta A, Caliolo C, Ciccarese M, Cinefra M, Romito S, Pisconti S, Prete SD, Aieta M, Rizzi D, Maiello E, Colucci G, Cinieri S. Orlando L, et al. Among authors: romito s. Breast. 2020 Oct;53:18-22. doi: 10.1016/j.breast.2020.06.002. Epub 2020 Jun 5. Breast. 2020. PMID: 32540553 Free PMC article. Clinical Trial.
No evidence of cardiomyopathy in spinal and bulbar muscular atrophy.
Querin G, Melacini P, D'Ascenzo C, Morandi L, Mazzini L, Silani V, Romito S, Mandrioli J, Raimondi M, Pegoraro E, Soraru' G. Querin G, et al. Among authors: romito s. Acta Neurol Scand. 2013 Dec;128(6):e30-2. doi: 10.1111/ane.12140. Epub 2013 May 16. Acta Neurol Scand. 2013. PMID: 23679084
Patients attitudes towards sleep disturbances during chemotherapy.
Romito F, Cormio C, De Padova S, Lorusso V, Berio MA, Fimiani F, Piattelli A, Palazzo S, Abram G, Dudine L, Guglielmi A, Galise I, Romito S, Mattioli V. Romito F, et al. Among authors: romito s. Eur J Cancer Care (Engl). 2014 May;23(3):385-93. doi: 10.1111/ecc.12106. Epub 2013 Aug 16. Eur J Cancer Care (Engl). 2014. PMID: 23947497
60 results